119 related articles for article (PubMed ID: 2827395)
1. Metabolism and pharmacokinetics of cinobufagin.
Toma S; Morishita S; Kuronuma K; Mishima Y; Hirai Y; Kawakami M
Xenobiotica; 1987 Oct; 17(10):1195-202. PubMed ID: 2827395
[TBL] [Abstract][Full Text] [Related]
2. [Metabolic fate of bufalin and cinobufagin].
Toma S; Hirai Y; Sugimoto C; Shoji M; Oguni Y; Morishita S; Ito C; Horie M
Yakugaku Zasshi; 1991 Nov; 111(11):687-94. PubMed ID: 1664463
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
[TBL] [Abstract][Full Text] [Related]
4. Urinary metabolites of cinobufagin in rats and their antiproliferative activities.
He X; Hu H; Wu Y; Zeng X
Nat Prod Res; 2012; 26(6):489-99. PubMed ID: 21711170
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
Terashita S; Tokuma Y; Fujiwara T; Shiokawa Y; Okumura K; Noguchi H
Xenobiotica; 1987 Dec; 17(12):1415-25. PubMed ID: 3439192
[TBL] [Abstract][Full Text] [Related]
8. Species differences in the metabolic conjugation of clofibric acid and clofibrate in laboratory animals and man.
Emudianughe TS; Caldwell J; Sinclair KA; Smith RL
Drug Metab Dispos; 1983; 11(2):97-102. PubMed ID: 6133730
[TBL] [Abstract][Full Text] [Related]
9. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
[TBL] [Abstract][Full Text] [Related]
10. The fate of amezinium in humans and animals.
Traut M; Kummer H; Brode E
Arzneimittelforschung; 1981; 31(9a):1616-22. PubMed ID: 7197976
[TBL] [Abstract][Full Text] [Related]
11. [Biochemical studies with oxitropium bromide. 1. Pharmacokinetics and metabolism in the rat and dog].
Wahl D; Förster HJ; Pook KH; Richter I
Arzneimittelforschung; 1985; 35(1A):255-65. PubMed ID: 4039166
[TBL] [Abstract][Full Text] [Related]
12. Metabolic fate of [14C]-brotizolam in the rat, dog, monkey and man.
Bechtel WD; Mierau J; Brandt K; Förster HJ; Pook KH
Arzneimittelforschung; 1986 Mar; 36(3A):578-86. PubMed ID: 3718581
[TBL] [Abstract][Full Text] [Related]
13. Major routes of naftifine biotransformation in laboratory animals and man.
Schatz F; Haberl H; Battig F; Jobstmann D; Schulz G; Nefzger M; Czok R; Nikiforov A
Arzneimittelforschung; 1986 Feb; 36(2):248-55. PubMed ID: 3964331
[TBL] [Abstract][Full Text] [Related]
14. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
15. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
[TBL] [Abstract][Full Text] [Related]
16. Carpipramine metabolism in the rat, rabbit and dog and in man after oral administration.
Bieder A; Decouvelaere B; Gaillard C; Gaillot J; Depaire H; Raynaud L; Snozzi C
Xenobiotica; 1985 May; 15(5):421-35. PubMed ID: 4036167
[TBL] [Abstract][Full Text] [Related]
17. Identification of cinobufagin metabolites in the bile of rats.
Ning J; Wu TH; Tian Y; Wang CY; Tian G; Zhang BJ; Liu KX; Ma XC
Xenobiotica; 2010 Jan; 40(1):48-54. PubMed ID: 19895259
[TBL] [Abstract][Full Text] [Related]
18. [Studies on the pharmacokinetics and biotransformation of ipratropium bromide in the rat and dog].
Förster HJ; Kramer I; Pook KH; Wahl D
Arzneimittelforschung; 1976; 26(5a):992-1005. PubMed ID: 134731
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of cinobufagin in rat liver microsomes. Identification of epimerized and deacetylated metabolites by liquid chromatography/mass spectrometry.
Zhang LS; Yoshida T; Aoki K; Kuroiwa Y
Drug Metab Dispos; 1991; 19(5):917-9. PubMed ID: 1686236
[TBL] [Abstract][Full Text] [Related]
20. In vivo metabolism of a new anticancer agent, 6-N-formylamino-12, 13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosil)5H-indolo [2,3-a]pyrrolo [3,4-c]carbazole-5,7(6H)-dione (NB-506) in rats and dogs: pharmacokinetics, isolation, identification, and quantification of metabolites.
Takenaga N; Ishii M; Nakajima S; Hasegawa T; Iwasa R; Ishizaki H; Kamei T
Drug Metab Dispos; 1999 Feb; 27(2):205-12. PubMed ID: 9929504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
